The Vagus nerve as a key mediator in the Microbiota-Gut-Brain axis: from Research to Clinical Implications


Date & Location
Saturday, December 8, 2018, 8:30 AM - 1:00 PM, WCMQ, Doha, Qatar

Overview
This activity is designed to bring an update on the recent advances done on the mechanisms that link the gut to the brain and inflammatory diseases, which will shape the future new options in treating inflammation and neurodegenerative diseases. We hope that this activity will: promote interactions and discussions between different medical specialties, and between physicians and scientists, provide physicians new tools to understand the Gut-Brain axis, provide an overview of clinical applications of the vagus nerve modulation, This activity will be a series of two presentations, followed by an interactive poll, which aims at providing attendants real time statistics on what the audience think about specific chosen questions. The activity will end with Q&A session. - Presentation 1: What?s the Gut-Brain axis? (includes a pre-poll) - Presentation 2: The Vagus nerve as a key mediator in the Microbiota-Gut-Brain axis: from Research to Clinical Implications - Post-Poll - Q&A The duration of the activity is about 2h. Please refer to the schedule for details

Target Audience
Allied Health Professionals, Dentists, Educators, Nurses, Pharmacists, Physicians, Researchers, Students

Objectives
  1. - Define the Microbiota-Gut-Brain axis,
  2. - Describe central and peripheral origins of inflammation,
  3. - Explain the role of the Vagus nerve in the Gut-Brain axis,
  4. - Discuss the importance of lifestyle (nutrition, antibiotic use, exercise etc) in microbiota diversity modulation and inflammatory processes,
  5. - Explain the role of vagus nerve stimulation,
  6. - Give clinical examples, which could benefit from modulating the Gut-Brain axis,

Registration
QAR 50 or $ 14

Accreditation


QCHP

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Qatar Council for Healthcare Practitioners (QCHP) of the Ministry of Public Health.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners-Accreditation Department and is approved for a maximum of 2.0 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Qatar Council for Healthcare Practitioners (QCHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.